Not applicableStudy completedNCT04749810What this trial is testingObservational Study of Elizaria® in aHUS PatientsWho this might be right forAtypical Hemolytic Uremic SyndromeaHUS AO GENERIUM 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05684159What this trial is testingStudy of NM8074 in Patients with AHUS with Evidence of Ongoing Thrombotic MicroangiopathyWho this might be right forAHUS - Atypical Hemolytic Uremic Syndrome NovelMed Therapeutics 12
Not applicableStudy completedNCT05405777What this trial is testingA Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South KoreaWho this might be right foraHUS Handok Inc. 97
Large-scale testing (Phase 3)Looking for participantsNCT05935215What this trial is testingEfficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Who this might be right forAtypical Hemolytic Uremic Syndrome Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00838513What this trial is testingOpen Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)Who this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00844428What this trial is testingOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUSWho this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT02222545What this trial is testingSafety and Efficacy Study of OMS721 in Patients With Thrombotic MicroangiopathiesWho this might be right forThrombotic Microangiopathies Omeros Corporation 58
Large-scale testing (Phase 3)Study completedNCT05876351What this trial is testingEculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in ChinaWho this might be right forAtypical Hemolytic Uremic Alexion Pharmaceuticals, Inc. 25
Not applicableActive Not RecruitingNCT06099236What this trial is testingA Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome PatientsWho this might be right forAtypical Hemolytic Uremic Syndrome(aHUS) AstraZeneca 367
Testing effectiveness (Phase 2)Study completedNCT00844844What this trial is testingOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSWho this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 1
Not applicableLooking for participantsNCT05996731What this trial is testingDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare DiseasesWho this might be right forAtypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic Kidney+1 more Mario Negri Institute for Pharmacological Research 105
Not applicableUnknownNCT03574506What this trial is testingEculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated aHUS: A Case SeriesWho this might be right forAtypical Hemolytic Uremic SyndromePregnancy Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia 50
Testing effectiveness (Phase 2)Study completedNCT01194973What this trial is testingAn Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic SyndromeWho this might be right forAtypical Hemolytic-Uremic Syndrome Alexion Pharmaceuticals, Inc. 44
Early research (Phase 1)Study completedNCT06004947What this trial is testingA Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant MedicationsWho this might be right forAnti-neutrophil Cytoplasmic Antibody-associated Vasculitis Amgen 32
Not applicableWithdrawnNCT02626663What this trial is testingThe Role of Microparticles as a BiomarkerWho this might be right forAtypical Hemolytic Uremic SyndromeThrombotic Thrombocytopenic PurpuraMicroparticles+1 more University of Rochester
Large-scale testing (Phase 3)Study completedNCT03131219What this trial is testingStudy of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)Who this might be right forAtypical Hemolytic Uremic Syndrome (aHUS) Alexion Pharmaceuticals, Inc. 34
Not applicableEnded earlyNCT02614898What this trial is testingEvaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and TreatmentWho this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 67
Not applicableStudy completedNCT01755429What this trial is testingTo Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS PatientsWho this might be right forATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Alexion Pharmaceuticals, Inc. 2
Not applicableStudy completedNCT01770951What this trial is testingA Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)Who this might be right forAtypical Hemolytic Uremic Syndrome (aHUS) Alexion Pharmaceuticals, Inc. 30
Not applicableLooking for participantsNCT04745195What this trial is testingComplement Prospective Evaluation of Thrombotic Microangiopathy on EndotheliumWho this might be right forThrombotic MicroangiopathiesHemolytic Uremic Syndrome, AtypicalHemolytic-Uremic Syndrome Maastricht University Medical Center 42